Mélanie Bézard

Characteristics and natural history of early-stage cardiac transthyretin amyloidosis

Steven Law, Mélanie Bézard, Aviva Petrie et al. · European Heart Journal · 2022 · 58 citations · Full text

Natural history and impact of treatment with tafamidis on major cardiovascular outcome‐free survival time in a cohort of patients with transthyretin amyloidosis

Mélanie Bézard, Mounira Kharoubi, Arnault Galat et al. · European Journal of Heart Failure · 2020 · 47 citations · Full text

Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide and High-Sensitivity Troponin T Levels in the Natural History of Transthyretin Amyloid Cardiomyopathy and Their Evolution after Tafamidis Treatment

Silvia Oghina, Constant Josse, Mélanie Bézard et al. · Journal of Clinical Medicine · 2021 · 32 citations · Full text

History of Extracardiac/Cardiac Events in Cardiac Amyloidosis: Prevalence and Time from Initial Onset to Diagnosis

Mounira Kharoubi, Mélanie Bézard, Arnault Galat et al. · ESC Heart Failure · 2021 · 32 citations · Full text

Assessing Cardiac Amyloidosis Subtypes by Unsupervised Phenotype Clustering Analysis

Louis Bonnefous, Mounira Kharoubi, Mélanie Bézard et al. · Journal of the American College of Cardiology · 2021 · 25 citations · Full text